News Breaks |
|
|
| April 19, 2012 |
| 10:55 EDT |  | BIIB, BIIB, BIIB, BIIB | Lazard to host a biotech breakfast meeting with a conference call hookup Breakfast Meeting to be held at the American Academy of Neurology's 62nd Annual Meeting in New Orleans. There will be a conference call hookup providing an update on Multiple Sclerosis with a focus on Biogen's BG-12. The breakfast meeting will be held at April 25 at 8 am with the Analyst/Industry conference call being held at 11 am. |
|
|
News For BIIB From The Last 14 Days Check below for free stories on BIIB the last two weeks. |
|
|
| May 24, 2013 |
| 07:20 EDT |  | BIIB | Celgene, Gilead, and Biogen could go much higher, says Bernstein
Subscribe for More Information |
|
| May 23, 2013 |
| 08:04 EDT |  | BIIB | Biogen appoints Spyros Artavanis-Tsakonas as Chief Scientific Officer
Subscribe for More Information |
|
| May 21, 2013 |
| 07:24 EDT |  | BIIB | Global Health Care to host a conference
Subscribe for More Information |
|
| 05:44 EDT |  | BIIB | Biogen submits application to FDA for approval of Plegridy in RMS
Subscribe for More Information |
|
| May 20, 2013 |
| 15:57 EDT |  | BIIB | Biogen IMS numbers should not be adjusted down at ISI Group ISI Group confirmed with Biogen that Tecfidera is not captured by IMS and numbers should not be adjusted downward to reflect free drugs dispensed. |
|
| 07:39 EDT |  | BIIB | Biogen weekly MS drug scripts up 26.5%, says Citigroup Citigroup says weekly scripts for Biogen's multiple sclerosis drug Tecfidera were up 26.5% to 1,621. Citi says the launch of Tecfidera is on track to beat Q2 estimates by a wide margin and it keeps a Buy rating on shares of Biogen. |
|
| May 16, 2013 |
| 07:29 EDT |  | BIIB | Leerink to host a bus tour Boston Biopharma Bus Tour travels throughout Boston on May 16-17. |
|
| May 14, 2013 |
| 15:09 EDT |  | BIIB | Biogen has a conference call hosted by JPMorgan JPMorgan Analysts Meacham and Kasimov host a conference call with CEO George Scangos and CFO Paul Clancy on May 17 at 10 am. |
|
| May 13, 2013 |
| 11:12 EDT |  | BIIB | Biogen MS drug scripts grew 38% week-over-week, says Leerink
Subscribe for More Information |
|
| 07:34 EDT |  | BIIB | Biogen says FDA accepts BLA for Eloctate
Subscribe for More Information |
| |
|
|
|
|